Charles Schwab’s Atossa Therapeutics ATOS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $66.4K | Sell |
80,000
-342,582
| -81% | -$284K | ﹤0.01% | 3435 |
|
2025
Q1 | $284K | Buy |
422,582
+120,934
| +40% | +$81.4K | ﹤0.01% | 3221 |
|
2024
Q4 | $285K | Sell |
301,648
-45,962
| -13% | -$43.4K | ﹤0.01% | 3277 |
|
2024
Q3 | $528K | Sell |
347,610
-22,378
| -6% | -$34K | ﹤0.01% | 3137 |
|
2024
Q2 | $440K | Buy |
369,988
+324,026
| +705% | +$386K | ﹤0.01% | 3253 |
|
2024
Q1 | $82.7K | Hold |
45,962
| – | – | ﹤0.01% | 3324 |
|
2023
Q4 | $40.4K | Hold |
45,962
| – | – | ﹤0.01% | 3421 |
|
2023
Q3 | $33.9K | Hold |
45,962
| – | – | ﹤0.01% | 3447 |
|
2023
Q2 | $57.9K | Hold |
45,962
| – | – | ﹤0.01% | 3400 |
|
2023
Q1 | $33.3K | Hold |
45,962
| – | – | ﹤0.01% | 3430 |
|
2022
Q4 | $24.3K | Hold |
45,962
| – | – | ﹤0.01% | 3477 |
|
2022
Q3 | $39K | Hold |
45,962
| – | – | ﹤0.01% | 3386 |
|
2022
Q2 | $51K | Sell |
45,962
-267,950
| -85% | -$297K | ﹤0.01% | 3389 |
|
2022
Q1 | $393K | Buy |
313,912
+14,481
| +5% | +$18.1K | ﹤0.01% | 3150 |
|
2021
Q4 | $480K | Hold |
299,431
| – | – | ﹤0.01% | 3156 |
|
2021
Q3 | $977K | Buy |
299,431
+5,473
| +2% | +$17.9K | ﹤0.01% | 2879 |
|
2021
Q2 | $1.86M | Buy |
293,958
+266,650
| +976% | +$1.69M | ﹤0.01% | 2739 |
|
2021
Q1 | $58K | Buy |
+27,308
| New | +$58K | ﹤0.01% | 3425 |
|